WuXi Biologics (02269.HK) issued 7.5 million shares due to the exercise of options.

Wisdom Financial News APP reported that WuXi Biologics (02269.HK) announced on November 12, 2025, that it issued 7.5 million ordinary shares to exercise options under the first public offering pre-purchase rights plan adopted by the company on January 5, 2016 (revised on August 10, 2016).